The Internet of Medical Things (IoMT) is the network of connected medical devices that collect, transmit, and act on health data, often in real time. These devices range from wearable heart monitors and smart insulin pumps to hospital imaging systems and remote patient monitoring platforms. The global IoMT market is projected to reach about $102 billion by 2026, with growth rates above 44% annually through 2034, reflecting how quickly healthcare is shifting toward connected technology.
If you’ve worn a fitness tracker that shares data with your doctor, used a connected blood pressure cuff at home, or had vitals automatically logged during a hospital stay, you’ve already encountered IoMT in practice. Here’s how the whole ecosystem works, what it’s doing for patients, and what risks come with it.
How IoMT Devices Work
At the most basic level, IoMT devices use sensors to measure something about your body or your environment, then send that information through a network to be stored, analyzed, or acted upon. The sensors involved cover a wide range of clinical measurements: electrocardiogram sensors track heart rhythm, pulse oximeters measure blood oxygen levels, photoplethysmography sensors estimate blood pressure from pulse wave patterns, and EEG sensors record brain activity. Simpler devices monitor temperature, heart rate, and respiration rate.
These sensors sit inside devices you might recognize: wearable patches, smartwatches, connected glucose monitors, smart inhalers, bedside hospital monitors, and even ventilators. What makes them “IoMT” rather than ordinary medical equipment is the connectivity layer. Each device transmits its readings over Wi-Fi, Bluetooth, or cellular networks to a clinical system where the data can be reviewed by a care team, trigger an alert, or feed into your electronic health record.
The devices generally fall into a few categories based on where they operate. On-body devices are wearables and implantables you carry with you. In-home devices include connected blood pressure monitors, smart pill dispensers, and remote monitoring kits. Community devices serve populations in pharmacies, clinics, or emergency vehicles. In-clinic and in-hospital devices include imaging systems, infusion pumps, and bedside monitors that feed data directly into hospital networks.
Remote Monitoring and Readmissions
One of the clearest benefits of IoMT is keeping tabs on patients after they leave the hospital. Remote patient monitoring lets care teams track vital signs, weight changes, and symptoms from a patient’s home, catching warning signs before they become emergencies.
Research published in Circulation found that hospitals offering remote monitoring services specifically designed for post-discharge care were significantly more likely to keep readmission rates below the national benchmark. For heart failure patients, those hospitals had roughly 33% higher odds of staying under the excess readmission threshold. For heart attack patients, the odds were about 29% higher. These aren’t small differences in a system where every avoided readmission represents both better outcomes for the patient and major cost savings for the hospital.
The practical experience for patients typically involves a kit sent home with a tablet, a connected scale, a blood pressure cuff, and sometimes a pulse oximeter. You take daily readings, the data uploads automatically, and a nurse reviews it remotely. If your weight spikes (a sign of fluid retention in heart failure) or your blood pressure trends upward, someone calls you before the situation escalates to an ER visit.
How Devices Share Data With Your Health Record
A connected glucose monitor is only useful if your endocrinologist can actually see the readings. This is where interoperability standards come in, and the dominant one right now is called FHIR (Fast Healthcare Interoperability Resources), developed by the health data standards organization HL7.
FHIR works like the common language between your medical devices, health apps, and electronic health records. It uses the same web technologies that power everyday websites and apps. When your phone’s health app requests your medication list from your health system’s server, it sends a structured web request, and the server responds with your data in a standardized format. This is the same basic mechanism behind any website you visit, just applied to clinical information with added security layers.
Before FHIR became widely adopted, getting data from a wearable sensor into a hospital’s electronic health record often required custom software for every combination of device and record system. FHIR provides a universal format so that a blood pressure reading from any connected cuff can be understood by any compatible health record. It’s now the primary standard for modern health data exchange, especially for mobile apps, patient portals, and API-based connections between systems.
Edge Computing and Faster Alerts
Most IoMT systems today send sensor data to the cloud for processing. That works fine for routine monitoring, but it introduces delays, privacy exposure, and bandwidth costs that become problematic when milliseconds matter.
Edge computing flips this model by running analysis directly on a local device or gateway rather than sending everything to a distant server. A research framework developed at Oxford University demonstrated what this looks like in practice: by processing patient data locally on a bedside gateway device, the system achieved 95% accuracy in detecting early signs of sepsis and heart failure with an average delay of just 2 milliseconds. Compared to cloud-based processing, it cut communication overhead by 90%.
For patients, this means a connected monitor in your hospital room or your home could identify a dangerous heart rhythm or early infection sign and alert your care team almost instantly, without waiting for data to travel to a cloud server, get processed, and send back a notification. It also means your raw health data stays local rather than traveling across the internet, which reduces privacy risk.
Smart Medication Devices
Smart pill bottles and automated dispensers represent another branch of IoMT aimed at a persistent problem: people not taking medications as prescribed. These devices can track when a bottle is opened, send reminders to your phone, and alert a caregiver or pharmacist if doses are missed.
The reality, though, is more nuanced than the marketing suggests. A scoping review published in JMIR Aging found that the impact of smart medication devices on adherence has been inconsistently defined and measured across studies. There’s no clear consensus that these products reliably improve medication-taking behavior. In some cases, devices that are difficult to use can actually make adherence worse, adding frustration and confusion to an already complex medication routine. The technology is promising in concept, but the evidence hasn’t caught up to the enthusiasm.
Cybersecurity Risks Are Widespread
Connected medical devices create a massive attack surface for hackers, and the healthcare industry has been slow to address it. A report covered by the HIPAA Journal found that 99% of hospitals are managing IoMT devices with known, exploitable security flaws. Of those, 96% had vulnerabilities specifically linked to ransomware campaigns.
The numbers get more specific by device type. About 28% of imaging systems (MRI machines, CT scanners, X-ray equipment) contained known exploitable vulnerabilities. Twenty percent of hospital information systems managing clinical and administrative data had flaws linked to ransomware groups, and many of those systems were insecurely connected to the internet. Common problems include default passwords that were never changed, hardcoded credentials built into the device software, and communication protocols that transmit data without encryption.
Russian cybercrime groups and other financially motivated attackers specifically target healthcare organizations because they combine a large number of connected devices, weak security infrastructure, and an urgent need to maintain access to patient data. Hospitals are seen as the critical infrastructure sector most likely to pay a ransom, because the alternative is disrupted patient care. When these devices are compromised, the consequences go beyond data theft. Imaging systems go offline, monitoring data becomes unreliable, and hospital operations grind to a halt.
How IoMT Devices Are Regulated
The FDA oversees IoMT devices in the United States, and a key regulatory category is Software as a Medical Device (SaMD). This covers software that performs a medical function on its own, without being part of a physical device. An app that analyzes heart rhythm data from a wearable sensor to detect atrial fibrillation, for example, qualifies as SaMD even though it’s just code running on a phone.
The FDA chaired an international working group through the International Medical Device Regulators Forum that established a risk-based framework for categorizing these products. Software that informs a clinical decision about a serious condition faces more scrutiny than software that tracks general wellness metrics. The framework covers how manufacturers should manage quality, evaluate clinical performance, and categorize risk. This means not every health app on your phone has gone through the same level of review. A step counter faces far less regulatory oversight than an algorithm that flags irregular heartbeats for your cardiologist.